Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Yousif, R. El-Helbawy, A. Darwish, H. Fathy, N. El-Helbawy (Shebin El-Kom, Egypt). Usefulness of procalcitonin as a diagnostic marker of pleural effusion. Eur Respir J 2012; 40: Suppl. 56, 2521

Member's Comments

No comment yet.

Related content which might interest you: Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Usefulness of pleural fluid C-reactive protein in differentiation of pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Diagnostic usefulness of tumour markers in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 The diagnostic value of CA-125 in pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 The diagnostic value of pleural fluid C-reactive protein level in pleural effusions Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Procalcitonin and CRP levels in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions? Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Efficacy of bronchoscopy as diagnostic method in pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 247s Year: 2004 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Value of non-invasive techniques in pleural effusions Source: ERS Skills Course 2015 Year: 2015 Value of pleural fluid and serum NT-ProBNP levels in differentiation of transudative and exudative pleural effusions Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions Year: 2010 Diagnostic value of C-reactive protein in exudative pleural effusions Source: International Congress 2019 – Clinical problems Year: 2019 The diagnostic usefulness of MAGE expression in the diagnosis of exudative pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Rapid evaluation of exudative pleural effusion using C-reactive protein Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009